Our portfolio includes ERZOFRI® (paliperidone palmitate), an FDA-approved long-acting injectable for schizophrenia and schizoaffective disorder, part of our broader commitment to supporting healthcare professionals in delivering consistent, long-term care and addressing the realities of treatment adherence.
Luye’s medical information resources are available to answer questions about our medicines, products and services, and for reporting side effects and product complaints.
Any personal data shared with us will always remain confidential.
Call 1-800-548-9765.
To report SUSPECTED ADVERSE EVENTS, contact Luye Pharma USA at 1-800-548-9765 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Please note that if you are a patient or member of the public, we cannot answer any questions about your medical condition or give any health advice. If you have any concerns about a personal medical condition, please consult your healthcare professional.
